Is your Peripheral IV Catheter protecting you and your patients?

90% of hospital inpatients receive an IV, yet 35-50% of those IVs fail1. That is not an acceptable outcome to the clinician, the hospital or, most importantly, the patient. Peripheral IV Catheter (PIVC) complications cause multiple restarts that affect everyone and everything, in almost every department. Additionally, IV catheters without blood control are still in use today. This puts you at risk of exposure to 30 dangerous bloodborne pathogens (BBPs), including hepatitis B, C, and HIV2.

What is the risk of blood exposure for you and your colleagues?

Not all Peripheral IV Catheters are created equal – devices without blood control are still in use today.

  • When healthcare workers use a PIVC without a blood control feature, blood leakage may occur during insertion up to 61% of the time5
  • Blood leakage exposes healthcare workers to more than 30 dangerous bloodborne pathogens, including hepatitis B, C, and HIV2

If 35-50% of PIVCs fail1, what is causing these failures?

Infection

Infection

The presence and growth of a pathogenic micro-organism(s) having a local or systemic effect3.

Phlebitis

Phlebitis

Inflammation of a vein4.

Occlusion

Occlusion

Obstruction of a vascular access device lumen, preventing or limiting the ability to flush and/or administer solutions through a lumen or withdraw blood3.

Dislodgement

Dislodgement

When the chosen securement method fails, and the catheter becomes displaced.

Extravasation

Extravasation

Inadvertent leakage of a vesicant solution into surrounding tissue4.

Interested in learning more?

Preserve sites and protect veins

Each time the PIVC is manipulated there is a risk of blood exposure and a greater chance of patient complications. Learn more about the various Vascular Access Device (VAD) guidelines and standards of practice.

The cost of peripheral IV catheters (PIVCs) on your healthcare organization goes beyond the price of the device

Selecting an IV catheter that can reduce the risk of complications could help you to reduce the economic burden of complications in your organization.

Hear a personal story about blood exposure from Cheryll Collins, BSN, RN, OCN from Nashville, Tennessee

Play

Placeholder

Where should you turn?

To the patient, complications, and the restarts they require are painful and risky. They can delay treatment and extend length of stay. They negatively impact the overall patient experience and mean additional work and stress for the clinician. Increased IV catheter restarts can have a dramatic impact on the hospital as well. Patient satisfaction is impacted, and the costs of increased product usage and lost efficiency can really add up.

Discover the BD Nexiva™ Closed IV Catheter System, shown to preserve sites for longer and designed to protect patients by reducing the risk of complications and restarts7,8*, and protect you on the job.

Placeholder

Given the dangerous bloodborne pathogens that can be transmitted through the blood, there is a personal risk to you as the clinician, should you be exposed.

To address the risk of exposure to bloodborne pathogens, consider blood control technology. BD Peripheral IV Catheters with Blood Control Technologies have been clinically demonstrated to reduce the risk of blood exposure by 95-98%6,7,*, **

Learn how you can make your IV practice safer for yourself and your patients.
Opt-in below to get connected with a BD sales representative and/or access our resources on the burden of blood exposure:

REFERENCES

*Compared to an open system
**Compared to a non-blood control catheter

1. Helm RE, Klausner JD, Klemperer JD, et al. Accepted but unacceptable: peripheral IV catheter failure. Infus Nurs Society. 2015;38(3):189-203.
2. European Biosafety Network. Prevention of Sharps Injuries in the Hospital and Healthcare Sector. European Biosafety Network Implementation Guidance Toolkit for EU Council Directive 2010/32/EU. January 2013 Available at: www.europeansafetynetwork.eu (accessed May 2017).
3. Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice. J Infus Nurs. 2021;44(suppl 1):S1-S224.
4. Canadian Vascular Access Association (2019). Canadian Vascular Access and Infusion Therapy Guidelines. Pembroke, ON: Pappin Communication
5. Haeseler G, Hildebrand M, Fritscher J. Efficacy and ease of use of an intravenous catheter designed to prevent blood leakage: A prospective observational study. J Vasc Access. 2015;16(3):233-236.
6. Onia R, Eshun-Wilson I, Arce C, Ellis C, Parvu V, Hassman D, Kassler-Taub K. Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure. Current medical research and opinion. 2011 Jul 1;27(7):1339-46.
7. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheterstabilization systems. J Infus Nurs. 2010;33(6):371-384.
8. González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.

BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.

Contact us | Unsubscribe | My profile


© BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. [BD-73356]



Privacy Policy | Terms of Use